Beam Therapeutics BEAM
NASDAQ BEAM
$25.81 +0.66 (+2.62%)
At close: Nov 11, 2026 · 4:00 PM EST

Beam Therapeutics (BEAM) Net Preferred Shares Issued and Repurchased (2019)

Updated

Beam Therapeutics (BEAM) reported Net Preferred Shares Issued and Repurchased of $37.9 million for FY2019.

Analysis

Beam Therapeutics (BEAM) Net Preferred Shares Issued and Repurchased (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Pref. Shares Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Beam Therapeutics 2.60 Bn -2.05 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 37.90 Mn
API Access

Beam Therapeutics Net Preferred Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=BEAM&period=max&api_key=YOUR_API_KEY